January 2, 2026 · Form 4 insider transaction
Kuriakose Emil sold 955 shares of Terns Pharmaceuticals Inc at $38.36 per share, a transaction worth $36.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Represents shares of common stock sold to satisfy taxes associated with the vesting of a restricted stock unit award previously granted to the Reporting Person. Such sales do not represent a discretionary trade by the Reporting Person.; This sale price represents the weighted average sale price of the shares sold ranging from $38.25 to $38.73 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.